Arjo ABFRA:A39 +0.54%73 Market Cap is €609.5 Mil as of Jun. 30, 2026. GuruFocus rates FRA:A39 with a GF Score™ of 73/100 and a GF Value™ of €3.27 (Significantly Undervalued). The stock has 5 warning signs investors should review. Among 120 Medical Distribution companies, Arjo AB ranks better than 71.67% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Arjo AB's share price for the quarter that ended in Mar. 2026 was €2.264. Arjo AB's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 272.4 Mil. Therefore, Arjo AB's market cap for the quarter that ended in Mar. 2026 was €616.6 Mil.
Arjo AB's quarterly market cap
declined
from Sep. 2025 (€807.8 Mil) to Dec. 2025 (€799.7 Mil) and
declined
from Dec. 2025 (€799.7 Mil) to Mar. 2026 (€616.6 Mil).
Arjo AB's annual market cap
declined
from Dec. 2023 (€969.6 Mil) to Dec. 2024 (€816.6 Mil) and
declined
from Dec. 2024 (€816.6 Mil) to Dec. 2025 (€799.7 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Arjo AB's Enterprise Value for Today is €641.4 Mil.
Arjo AB (FRA:A39) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Arjo AB Market Cap Related Terms
Arjo AB Market Cap Historical Data
* Premium members only.
The historical data trend for Arjo AB's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Arjo AB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Arjo AB Market Cap vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Arjo AB's Market Cap distribution charts can be found below:
* The bar in red indicates where Arjo AB's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Arjo AB's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Arjo AB (FRA:A39) has a Market Cap of €609.5 Mil as of Jun. 30, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Arjo AB and its competitors. According to the industry distribution chart, Arjo AB ranks #34 out of 120 companies in the Medical Distribution industry, placing it in the top 28.3%.
Is Arjo AB's Market Cap too high?
Arjo AB's current Market Cap is €609.5 Mil. Based on the distribution chart, Arjo AB ranks #34 out of 120 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Arjo AB has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Arjo AB's Market Cap compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Arjo AB ranks #34 out of 120 companies for Market Cap. This puts Arjo AB in the upper half of its industry. The industry median Market Cap is 145.30. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Distribution company?
The median Market Cap among Medical Distribution companies is 145.30, based on 120 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Arjo AB and its competitors. For the Medical Distribution industry, the median Market Cap is 145.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Arjo AB's current Market Cap is €609.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arjo AB stock overvalued right now?
Based on GuruFocus' analysis, Arjo AB (FRA:A39) is currently considered Significantly Undervalued. The stock's GF Value™ is €3.27, compared to a current price of €2.22 — trading 32% below its estimated fair value. The current Market Cap is €609.5 Mil. Arjo AB's overall GF Score™ is 73/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Arjo AB (FRA:A39), the current Market Cap is €609.5 Mil as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Arjo AB (FRA:A39) Overvalued in 2026?
Based on GuruFocus' analysis, Arjo AB stock appears to be undervalued.
The current stock price of €2.22 is trading 32% below its estimated GF Value™ of €3.27.
GuruFocus considers Arjo AB to be Significantly Undervalued.
Key valuation signals for FRA:A39:
Market Cap: €609.5 Mil
GF Value™: €3.27 vs. price of €2.22 (32% below fair value)
No single metric tells the full story. See the FRA:A39 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Arjo AB is a supplier of medical devices, services, and solutions in Sweden. It serves its services to private and public institutions with acute care and long-term care. The company's offering includes products and solutions for patient handling, hygiene, disinfection, medical beds, therapeutic surfaces, venous thromboembolism (VTE) prevention and diagnostics. The company includes segments: Global Sales, North America, Diagnostics.
73GF Score
Get the complete analysis for FRA:A39
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:A39 has been successfully added to your 
